Wang, Jiabin – Trademark Portfolio

Entity Type: 01

Wang, Jiabin holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SIFLOWSEA. The owner is based in Luoyang, Henan.

Neibu Township, Ruyang County

Group 2, Dongjinzhuang Village

Luoyang, Henan 471200 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIFLOWSEA
SIFLOWSEA
Registered 2025
NUONU
NUONU
Abandoned 2023

Trademark Classifications

Wang, Jiabin's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Wang, Jiabin have?

Wang, Jiabin has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Wang, Jiabin file in?

Wang, Jiabin files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Wang, Jiabin's most well-known trademarks?

Wang, Jiabin's registered trademark portfolio includes well-known marks such as SIFLOWSEA. These are among 1 currently registered trademark in the portfolio.

What is Wang, Jiabin's trademark registration success rate?

Wang, Jiabin has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.